Focused on exosome-isolation technology to improve global health outcomes by enabling tests that better detect a range of conditions, including early stage cancer, treatment response, and cancer recurrence. Using exosomes, these test can provide higher sensitivity than competing approaches by enabling a simple, reliable, and automated workflow.